ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

XLO Xilio Therapeutics Inc

1.1799
0.1299 (12.37%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Xilio Therapeutics Inc XLO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.1299 12.37% 1.1799 13:00:11
개장가 저가 고가 종가 전일 종가
1.06 1.04 1.2199 1.18 1.05
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/04/202405:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
28/03/202420:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
28/03/202420:00BWGilead and Xilio Announce Exclusive License Agreement for..
29/02/202406:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
01/02/202406:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
20/01/202406:30EDGAR2Form 8-K - Current report
08/01/202421:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
04/01/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:05EDGAR2Form 8-K - Current report
07/12/202321:45EDGAR2Form 8-K - Current report
07/12/202321:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
10/11/202306:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:13EDGAR2Form 8-K - Current report
10/11/202306:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202306:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202306:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/11/202306:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
04/11/202305:05EDGAR2Form 8-K - Current report
04/11/202301:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
31/10/202322:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
28/09/202306:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
08/09/202305:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202305:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/09/202321:35EDGAR2Form 8-K - Current report
05/09/202321:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05/09/202320:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19/08/202309:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/08/202309:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202320:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:40EDGAR2Form 8-K - Current report
14/08/202320:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
08/08/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202305:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/08/202305:15EDGAR2Form 8-K - Current report
04/08/202305:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
26/05/202306:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09/05/202320:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..

최근 히스토리

Delayed Upgrade Clock